It has been reported that CYP27A1 activity can be inhibited in vitro by anastrozole but not by exemestane and letrozole [44] suggesting another level of complexity to the prognostic impact of CYP27A1 in postmenopausal BC that needs to be investigated. Here, CYP27A1 is linked to breast cancer.